Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. [electronic resource]
Producer: 20040105Description: 4428-38 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Area Under Curve
- Contrast Media
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neoplasms -- blood supply
- Neovascularization, Pathologic -- drug therapy
- Stilbenes -- administration & dosage
- Tomography, Emission-Computed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.